This Solicitation opportunity from Department Of Defense was posted on May 27, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
DIBUCAINE OINTMENT
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
Dibucaine Ointment, USP, containing 1 percent dibucaine as the active ingredient, is procured under solicitation SPE2DP-26-T-3558 for government use as a topical rectal medication administered externally. The product is supplied in collapsible tubes with rectal applicators, with each unit of issue being one ounce or 28 grams, and must have a minimum of 31 months of remaining shelf life upon receipt by the first government activity, given its total 36-month non-extendable shelf life as a Type I item. Storage must be maintained between 15–30°C (59–86°F), and all packaging and labeling must comply with the Medical Marking Standard No. 1, which supersedes MIL-STD-129 for medical items; each unit must be marked with the National Stock Number, manufacturer name, date of manufacture, expiration or retest date, contract number, and lot number. The item is regulated by the FDA, and contractors must submit a referral in EBS with bidder and manufacturer details for confirmation prior to award. Packaging must be commercial and designed to protect against damage and breakage, with non-hazardous materials complying with ASTM D3951 while hazardous materials follow TQ requirement IP025 per FED-STD-313; palletization must adhere to DLA Packaging Requirements for Procurement RP001. Delivery is FOB destination with a five-day delivery window from order placement, and all items must be delivered to the specified destination without the use of parcel post, instead requiring traceable shipping methods. Invoicing must be submitted exclusively through WAWF, and acceptance and inspection occur at the point of delivery. The contract includes mandatory federal acquisition regulation clauses covering equal opportunity, combating trafficking, employment eligibility verification, cybersecurity safeguards, hazardous material handling, and prohibitions on items sourced from Communist Chinese military companies. Contractors are required to provide accurate Unique Entity Identifiers and CAGE codes, represent their small business status if applicable, and disclose joint venture participation and covered telecommunications equipment. Deviations are noted for several clauses, including trafficking in persons and cybersecurity assessment requirements. All DLA Master List of Technical and Quality Requirements take precedence over alternate standards, and Safety Data Sheets must be provided in accordance with regulatory requirements. This procurement targets the fulfillment of medical supply chain needs for DoD operations under the authority of the Medical Supply Chain Pharm FSA, with no pricing provided in the solic
General Info
Agency
NAICS
Place of Performance
UNIT 100522 BOX 1, FPO, AA, 34089, USASet-Aside
Timeline
Submission Closed
Organization & Contact Information
Full Description
DIBUCAINE OINTMENT,USP
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
.
CONTAINS 1 PERCENT OF DIBUCAINE OINTMENT
AS THE ACTIVE INGREDIENT
.
COMES SUPPLIED IN A COLLAPSIBLE TUBE
AND RECTAL APPLICATOR
.
RECTALLY ADMINISTERED
.
FOR EXTERNAL USE ONLY
.
UNIT OF ISSUE IS A PACKAGE CONTAINING
ONE (1) OUNCE OR 28 GRAMS
.
TOTAL SHELF LIFE IS 36 MONTHS.
.
THERE SHALL BE A MINIMUM OF 31 MONTHS
OF REMAINING SHELF LIFE AT THE TIME OF RECEIPT
BY THE FIRST GOVERNMENT ACTIVITY.
.
STORE AT 15-30 DEGREES CELSIUS OR
59 TO 86 DEGREES FARENHEIT
.
LABELING AND MARKING:
MUST INCLUDE THE FOLLOWING:
NATIONAL STOCK NUMBER,
MANUFACTURER,
DATE OF MANUFACTURER,
EXPIRATION DATE OR RETEST DATE,
CONTRACT NUMBER
AND LOT NUMBER
.
1/7/2015
1 PG = 28 GM
.
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description.
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
SPE2DP-26-T-3558
SECTION B
PACKAGING AND PACKING SHALL BE COMMERCIAL AS
SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED
IN A SUITABLE SEALED UNIT CONTAINER CAPABLE
OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR
BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RS020: Shelf-life requirement RS001 for a TYPE I (CODE Q) item with a shelf life of 36 months (non-extendable) applies to this item.
THE HARVARD DRUG GROUP, L.L.C. 1LEZ0 P/N NDC00536-1211-95
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7016918203 0001 PG 2.000
NSN/MATERIAL:6505002999535
DELIVERY (IN DAYS):0005
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA-QUP:001
IF MATERIAL IS CONSIDERED HAZARDOUS IAW FED-STD-313,
PACKAGE IN ACCORDANCE WITH TQ REQUIREMENT IP025.
IF THE MATERIAL IS NOT CONSIDERED HAZARDOUS, IN ACCORDANCE WITH
FED-STD-313, THE MATERIAL SHALL BE COMMERCIALLY PACKAGED IN ACCORDANCE
SPE2DP-26-T-3558
SECTION B
PR: 7016918203 PRLI: 0001 CONT’D
WITH ASTM D3951.
All DLA Master List of Technical and Quality Requirements take precedence over ASTM D3951. Mark and label all packaging and packing in accordance with MIL-STD-129. The Unit of Issue (U/I) and Quantity per Unit Pack (QUP) will be as specified in the contract/purchase order. PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
PARCEL POST ADDRESS:
N24305
USNS HERSHEL WILLIAMS
OFFICER IN CHARGE
UNIT 100522 BOX 1
FPO AA 34089
US
SHIP BY FASTEST TRACEABLE MEANS. DO NOT USE PARCEL POST.
FREIGHT SHIPPING ADDRESS:
N24305
USNS HERSHEL WILLIAMS
DLA VENDORS: USE VSM FOR
US
M/F: (TCN) N243056144S040
RDD: 164
PROJ: HJ5 TP 2
SUPP ADD: YMEDIC SIG: A
FOR GOVERNMENT USE ONLY: (IPD) 06
DIC: A4A DIST: 9B ADV: 2A FC: E5
Need Ship Date:00/00/0000 Original Required Delivery Date:05/29/2026
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0002 7016935834 0001 PG 1.000
NSN/MATERIAL:6505002999535
DELIVERY (IN DAYS):0005
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
SPE2DP-26-T-3558
SECTION B
PR: 7016935834 PRLI: 0001 CONT’D
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
SPECIAL NSN/Part Number: 6505-00-299-9535 Quantity: 2 PG Purchase Request: 7016935834QTY: 1 Delivery: 5 days ADO
More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS